Telesis Bio Common Stock

Telesis Bio (TBIO) currently reports a common stock of $0 as of September 2024. That compares with $5K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Telesis Bio's common stock history and peer comparisons.

Telesis Bio's common stock decreased from $5K to $0 — a 100.0% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Telesis Bio reported $0 in common stock as of September 2024. That compares with $5K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Telesis Bio, and consider following TBIO for alerts when major investors trade the stock.

Telesis Bio is classified in the Healthcare sector. On common stock, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TBIO with unrelated industries.